Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ACTRN12608000200381
ACTRN12608000200381CompletedPhase 2

Effects of early luteal phase vaginal progesterone supplementation on the outcome of in-vitro fertilization and embryo transfer

The Chinese University of Hong Kong0 sites196 target enrollmentStarted: April 14, 2008Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
196
Study OverviewStudy DesignEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
20 Years to 39 Years (—)
Sex
Female

Inclusion Criteria

  • •women undergoing the treatment of in-vitro fertilization and embryo transfer, with HCG administration as the standard luteal phase support

Exclusion Criteria

  • •age = 40 year-old
  • •use of vaginal progesterone for luteal phase support because of risk of ovarian hyperstimulation syndrome
  • •distorted uterine cavity, e.g. due to submucosal fibroids or uterine anomalies

Investigators

Similar Trials

Recruiting
Not Applicable
Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsiaHigh risk pregnancy.Supervision of high risk pregnancy
IRCT20151228025732N72Semnan University of Medical Sciences60
Completed
Phase 2
Evaluation of the effect of progesterone on latency period of preterm premature rupture of membranePremature rupture of membranes
IRCT2014020216453N1Research chancelor of kerman University of Medical Sciences171
Completed
Phase 3
Evaluation of the effect of vaginal Progesterone in preventing preterm laborprevention of preterm labor.Preterm labour
IRCT138706051096N1Vice Chancellor for research-Guilan University of Medical Sciences260
Completed
Phase 2
Vaginal Progesterone effect on pregnancy rate in infertility women with polycystic ovarian syndromeInfertility and Polycystic Ovarian Syndrome.Polycystic ovarian syndrome
IRCT201206072967N4Vice chancellor of research, Kashan University of Medical Sciences200
Active, not recruiting
Phase 1
The Effect of Vaginal Progesterone Administration in the prevention of Preterm Birth in Women with Short Cervix, [also Known as: Vaginal progesterone bioadhesive gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix-Trial (PREGNANT Short Cervix-Trial)] - PREGNANT Short Cervix-TrialPreterm birth (less than or equal to 32 6/7 weeks gestation)
EUCTR2008-007498-19-CZColumbia Laboratories, Inc450